Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

The Long Game: Inside Rare Cannabinoid Company’s Bet on the Future of Cannabinoids

The hemp boom moved fast. In the years following the 2018 Farm Bill, thousands of…

14 hours ago

A Rare South American Cannabis Power Move Is Taking Shape In Argentina

Flowers & Terps and Universal Growing are joining forces in a move that blends flower…

14 hours ago

The Best Rolling Papers on Earth, According to High Times Readers

Rolling papers aren’t props. They’re the instrument that sets the pace and feel of a…

14 hours ago

Colombian President Says ‘Weed Was for Protest, Cocaine Is the Drug of Capital’

Yesterday, Colombian President Gustavo Petro appeared before the UN Commission on Narcotic Drugs, where he…

2 days ago

Before Weed Learned To Fake Female Empowerment, Harlee Case Made It Real. Now She’s Giving It A Soundtrack.

Before New Constellations started turning heads with dreamy synth-pop and soft-focus heat, Harlee Case was…

2 days ago

New High Times Documentary Explores the Blunt’s Next Chapter

In High Times’ new documentary on Rove, one of cannabis culture’s most enduring rituals gets…

2 days ago